Table 2.
Recurrence characteristics.
| Characteristics | Number (Range, %) |
|---|---|
| N° patients | 21 |
| Median Age (years) | 68 (50–75) |
| Media BMI (Kg/m2) | 27.4 (20–40) |
| Surgical approach | |
| Laparotomy | 6 (28.6%) |
| Vaginal surgery | 1 (4.8%) |
| Minimally invasive surgery | 14 (66.6%) |
| Histologic tumor grading | |
| G1 | 6 (28.6%) |
| G2 | 15 (71.4%) |
| Median tumour size (mm) | 20 (15–34) |
| Recurrence site | |
| Vaginal | 7 (33.3%) |
| Lymph nodes | 3 (14.3%) |
| Distant | 11 (52.4%) |
| Recurrence L1-CAM+ | |
| Vaginal | 4 (57.1%) |
| Lymph nodes | 1 (33.3%) |
| Distant | 11 (100%) |
| No Value | 2 (9.5%) |
| Recurrence therapy | |
| Surgery + RT | 7 (33.3%) |
| Surgery + CT | 3 (14.3%) |
| CT | 11 (52.4%) |
| Median DFS (months) | 47 (5.4–130.7) |
| Median OS (months) | 74.6 (10.9–141.2) |
| Follow-up Status | |
| NED | 5 (23.8%) |
| AWD | 4 (19%) |
| DOD | 12 (57.2%) |
BMI: Body Mass Index; RT: Radiotherapy; CT: Chemotherapy; DFS: Disease free survival; OS: Overall survival; NED: No evidence of disease; AWD: Alive with disease; DOD; Death of disease.